文献速递冠心病

左主干分叉支架术后残余缺血与心血管死亡的关系

Left main bifurcation stenting: impact of residual ischaemia on cardiovascular mortality.
PubMed 文献 · Eur Heart J · 2023-01-01

本研究纳入1170例左主干分叉PCI术后有可分析μQFR的患者,定义术后μQFR≤0.80为生理性显著残余缺血。13.2%患者存在残余缺血,其3年心血管死亡风险显著升高(5.4% vs 1.3%,校正HR 3.20),BOCE风险亦升高(17.8% vs 5.8%,校正HR 2.79)。

要点

  • 左主干分叉PCI术后μQFR评估的残余缺血发生率为13.2%
  • 残余缺血者3年心血管死亡风险增加约3倍(校正HR 3.20)
  • 术后μQFR每降低0.1,心血管死亡风险增加27%

核心结论

  • 左主干分叉PCI术后μQFR评估的残余缺血与3年心血管死亡风险升高独立相关。

主要发现

  • 155例(13.2%)患者LAD或LCX存在术后μQFR≤0.80的残余缺血。
  • 残余缺血组3年心血管死亡率为5.4%,无残余缺血组为1.3%,校正HR 3.20(95%CI 1.16-8.80)。
  • 残余缺血组3年BOCE发生率为17.8%,无残余缺血组为5.8%,校正HR 2.79(95%CI 1.68-4.64)。
  • 心血管死亡与靶分叉相关心肌梗死复合终点发生率残余缺血组为14.0%,无残余缺血组为3.3%,校正HR 4.06(95%CI 2.22-7.42)。
  • 术后μQFR每降低0.1,心血管死亡HR 1.27(95%CI 1.00-1.62),BOCE HR 1.29(95%CI 1.14-1.47)。

关键数值与推荐

  • 生理性显著残余缺血定义为术后μQFR值在LAD或LCX≤0.80。

临床怎么用

  • 左主干分叉PCI术后可考虑行μQFR生理学评估以识别残余缺血高危患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The present study sought to determine the rate and prognostic implications of post-procedural physiologically significant residual ischemia according to Murray law-based quantitative flow ratio (μQFR) after left main (LM) bifurcation percutaneous coronary intervention (PCI). METHODS AND RESULTS: Consecutive patients undergoing LM bifurcation stenting at a large tertiary care center between January 2014 and December 2016 with available post-PCI μQFR were included. Physiologically significant residual ischemia was defined by post-PCI μQFR values ≤0.80 in the left anterior descending (LAD) or left circumflex artery (LCX). The primary outcome was 3-year cardiovascular death. The major secondary outcome was 3-year bifurcation-oriented composite endpoint (BOCE). Among 1170 included patients with analyzable post-PCI μQFR, 155 (13.2%) had residual ischemia in either LAD or LCX. Patients with vs. those without residual ischemia had a higher risk of 3-year cardiovascular mortality [5.4% vs. 1.3%; adjusted hazard ratio (HR) 3.20, 95% confidence interval (CI): 1.16-8.80]. The 3-year risk of BOCE was significantly higher in the residual ischemia group (17.8% vs. 5.8%; adjusted HR 2.79, 95% CI: 1.68-4.64), driven by higher incidence of the composite of cardiovascular death and target bifurcation-related myocardial infarction (14.0% vs. 3.3%; adjusted HR 4.06, 95% CI: 2.22-7.42). A significant, inverse association was observed between continuous post-PCI μQFR and the risk of clinical outcomes (per 0.1 μQFR decrease, HR of cardiovascular death 1.27, 95% CI: 1.00-1.62; HR of BOCE 1.29, 95% CI: 1.14-1.47). CONCLUSION: After angiographically successful LM bifurcation PCI, residual ischemia assessed by μQFR was identified in 13.2% of patients and was associated with higher risk of 3-year cardiovascular death, indicating the superior prognostic value of post-PCI physiological assessment.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Wang HY, Zhang R, Dou K, et al. Left main bifurcation stenting: impact of residual ischaemia on cardiovascular mortality. Eur Heart J. 2023. PMID: 37188864. doi:10.1093/eurheartj/ehad318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。